| | TNFα | S100B |
---|
LPS IP | Serum (30 min) | ↑ | -- |
| Serum (24 h) | ↑ | -- |
| CSF (30 min) | -- | ↑ |
| CSF (24 h) | -- | -- |
LPS ICV | Serum (30 min) | ↑ | -- |
| Serum (24 h) | -- | -- |
| CSF (30 min) | -- | ↑ |
| CSF (24 h) | ↑ | ↑ |
- ↑ indicates a significant increase compared to control, with a significance level of p < 0.05; -- indicates no significant difference compared to control. See Table 1, Table 2 and Figure 1 for details.